Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

The Bronchiectasis Severity Index. An International Derivation and Validation Study

Open access
Chalmers, James D., Goeminne, Pieter, Aliberti, Stefano, McDonnell, Melissa J., Lonni, Sara, Davidson, John, Poppelwell, Lucy, Salih, Waleed, Pesci, Alberto, Dupont, Lieven J., Fardon, Thomas C., De Soyza, Anthony, Hill, Adam T. · 2014 · American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis. Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for future research. Objectives: This study describes the derivation and validation of the Bronchiectasis Severity Index (BSI). Methods: Derivation of the BSI used data from a prospective cohort study (Edinburgh, UK, 2008–2012) enrolling 608 patients. Cox proportional hazard regression was used to identify independent predictors of mortality and hospitalization over 4-year follow-up. The score was validated in independent cohorts from Dundee, UK (n = 218); Leuven, Belgium (n = 253); Monza, Italy (n = 105); and Newcastle, UK (n = 126). Measurements and Main Results: Independent predictors of future hospitalization were prior hospital admissions, Medical Research Council dyspnea score greater than or equal to 4, FEV1 < 30% predicted, Pseudomonas aeruginosa colonization, colonization with other pathogenic organisms, and three or more lobes involved on high-resolution computed tomography. Independent predictors of mortality were older age, low FEV1, lower body mass index, prior hospitalization, and three or more exacerbations in the year before the study. The derived BSI predicted mortality and hospitalization: area under the receiver operator characteristic curve (AUC) 0.80 (95% confidence interval, 0.74–0.86) for mortality and AUC 0.88 (95% confidence interval, 0.84–0.91) for hospitalization, respectively. There was a clear difference in exacerbation frequency and quality of life using the St. George’s Respiratory Questionnaire between patients classified as low, intermediate, and high risk by the score (P < 0.0001 for all comparisons). In the validation cohorts, the AUC for mortality ranged from 0.81 to 0.84 and for hospitalization from 0.80 to 0.88. Conclusions: The BSI is a useful clinical predictive tool that identifies patients at risk of future mortality, hospitalization, and exacerbations across healthcare systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201309-1575oc

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 1,093

Metadata

Authors
Chalmers, J. D., Goeminne, P., Aliberti, S., McDonnell, M. J., Lonni, S., Davidson, J., Poppelwell, L., Salih, W., Pesci, A., Dupont, L. J., Fardon, T. C., De Soyza, A., & Hill, A. T.
Affiliations
  • University of Dundee (GB)
  • Universitair Ziekenhuis Leuven (BE)
  • University of Milano-Bicocca (IT)
  • Freeman Hospital (GB)
  • Adult Bronchiectasis Service and Sir William Leech Centre for Lung Research, Freeman Hospital, Newcastle upon Tyne Hospitals, Heaton, Newcastle, United Kingdom
  • Edinburgh Royal Infirmary (GB)
Corresponding author
Chalmers, James D.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2014-03-01
Volume
189
Issue
5
Pages
576-585
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1992873661
Cited by
1,093
References
31
Citations by year
2026: 94 · 2025: 94 · 2024: 142 · 2023: 75 · 2022: 96 · 2021: 97 · 2020: 101 · 2019: 75 · 2018: 100 · 2017: 96 · 2016: 57 · 2015: 45 · 2014: 18
FWCI
57.65
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Wellcome Trust
  • Health Research Board
  • Medical Research Council (MR/L011263/1)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords
Bronchiectasis Severity Index, bronchiectasis, risk stratification, mortality prediction, hospitalization prediction, exacerbations, Pseudomonas aeruginosa colonization, dyspnea, FEV1, St George's Respiratory Questionnaire, quality of life
MeSH terms
Adult, Aged, Aged, 80 and over, Bronchiectasis, Decision Support Techniques, Exercise Test, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Surveys and Questionnaires, Respiratory Function Tests, Risk Factors, Severity of Illness Index, Proportional Hazards Models, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Bronchiectasis Severity Index. An International Derivation and Validation Study. https://app.cochat.ai/papers/10.1164/rccm.201309-1575oc
The paper
Chalmers, J. D., Goeminne, P., Aliberti, S., McDonnell, M. J., Lonni, S., Davidson, J., Poppelwell, L., Salih, W., Pesci, A., Dupont, L. J., Fardon, T. C., De Soyza, A., & Hill, A. T. (2014). The Bronchiectasis Severity Index. An International Derivation and Validation Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201309-1575oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.